<DOC>
	<DOCNO>NCT02569086</DOCNO>
	<brief_summary>Antibiotic dosing severe septic patient pose challenge clinician due pharmacokinetic change see population . Piperacillin/tazobactam often use empirical treatment , initial appropriate dose crucial reduce mortality . The investigator aim determine pharmacokinetic profile piperacillin 4g every 8 hour 20 patient treat empirically severe sepsis . A PK population model establish dual purpose assess current standard treatment simulate alternative dosing regimen modes administration . Time minimal inhibitory concentration ( T &gt; MIC ) predict patient evaluate MIC pathogen detect . Pharmacokinetic-pharmacodynamic ( PK-PD ) target evaluate 100 % f T &gt; MIC 50 % fT &gt; 4xMIC . Only patient prescribe piperacillin empirically treat physician enrol study . The investigator influence choice treatment prescribed patient .</brief_summary>
	<brief_title>Piperacillin PK Analysis Severe Sepsis Patients</brief_title>
	<detailed_description />
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<mesh_term>Piperacillin</mesh_term>
	<criteria>Treatment Piperacillin/Tazobactam 4g/0.5g every 8 hour le 48 hour renal replacement therapy Age 18</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>